Publicações Artigos Científicos Anais em Eventos Todos os tipos
Ano de publicação:

Hipotensiva


Natural And Artificial Inhibitors Of Snake Venom Phospholipases A2


Silveira, LB(1); Marcussi, S(2); Ticli, FK(3); Urzeda, MA(2); Biondo, R(2); França, SC(2); Pereira, PS(2); Soares, AM(2)


Natural And Artificial Inhibitors Of Snake Venom Phospholipases A2

Phospholipases A2 (PLA2) from snake venoms induce different toxic and pharmacological effects including myotoxicity, edema, hypotension, platelet aggregation inhibition, convulsion, anticoagulation and others. Natural PLA2 inhibitors were found in different organisms as plants, marine animals, snake and opossum plasmas. Functional characterization of natural (MMV from Taberna montana extract; manoalid A, from marine animal; heparin, from human blood; BmjMIP, from B. moojeni plasma; CAB from opossum plasma) and synthetic inhibitors (manoalid B, p-bromophenacil bromide BPB, EDTA), upon the enzymatic and pharmacological activity of PLA2 from Bothrops and Crotalus snake venome. PLA2 was assayed in gels, while the myotoxic and edema inducing were evaluated in vivo. PrTX-I and III (from B. pirajai), BthTX-I and II (from B. jararacussu), crotoxin and CB (from C. durissus terrificus), in the presence or absence of different inhibitors, following an incubation of 30 minutes at 37ºC were used. Among the natural inhibitors, the following decreasing range of activity was observed: BmjMIP > manoalid A > CAB > heparin > MMV; for the synthetic ones, the sequence was: BPB > manoalid B > EDTA. Different levels of inhibition among PLA2s from Bothrops and Crotalus venoms were also detected. Natural inhibitors were more efficient than synthetic ones for neutralization of the toxic and enzymatic effects induced by PLA2s. Structural and interaction studies are needed to a better understanding of inhibitory effect in order to design new models of more potent synthetic inhibitors.


SBTox 2003



Structure of BthA-I complexed with p-bromophenacyl bromide: possible correlations with lack of pharmacological activity


aMagro AJ,aTakeda AA,bSoares AM,aFontes MR


The crystal structure of an acidic phospholipase A2 isolated from Bothrops jararacussu venom (BthA-I) chemically modified with ρ-bromophenacyl bromide (BPB) has been determined at 1.85 Å resolution. The catalytic, plateletaggregation inhibition, anticoagulant and hypotensive activities of BthA-I are abolished by ligand binding. Electron-density maps permitted unambiguous identification of inhibitor covalently bound to His48 in the substrate-binding cleft. The BthA-I–BPB complex contains three structural regions that are modified after inhibitor binding: the Ca2+- binding loop, β-wing and C-terminal regions. Comparison of BthA-I–BPB with two other BPB-inhibited PLA2 structures suggests that in the absence of Na+ ions at the Ca2+-binding loop, this loop and other regions of the PLA2s undergo structural changes. The BthA-I–BPB structure reveals a novel oligomeric conformation. This conformation is more energetically and conformationally stable than the native structure and the abolition of pharmacological activities by the ligand may be related to the oligomeric structural changes. A residue of the ‘pancreatic’ loop (Lys69), which is usually attributed as providing the anticoagulant effect, is in the dimeric interface of BthA-I–BPB, leading to a new hypothesis regarding the abolition of this activity by BPB.


Acta Cryst. (2005). D61, 1670–1677

phospholipase A2; platelet aggregation and hypotensive effects; p-bromophenacyl bromide; oligomeric changes



Crystal structure of an acidic platelet aggregation inhibitor


Magro AJa, Murakami MTb, Marcussi Sc, Soares AMc, Arni RKb, Fontes MRa


Phospholipases A2 belong to the superfamily of proteins which hydrolyzes the sn-2 acyl groups of membrane phospholipids to release arachidonic acid and lysophospholipids. An acidic phospholipase A2 isolated from Bothrops jararacussu snake venom presents a high catalytic, platelet aggregation inhibition and hypotensive activities. This protein was crystallized in two oligomeric states: monomeric and dimeric. The crystal structures were solved at 1.79 and 1.90 Å resolution, respectively, for the two states. It was identified a Na+ ion at the center of Ca2+-binding site of the monomeric form. A novel dimeric conformation with the active sites exposed to the solvent was observed. Conformational states of the molecule may be due to the physicochemical conditions used in the crystallization experiments. We suggest dimeric state is one found in vivo.


Biochemical and Biophysical Research Communications 323 (2004) 24–31

X-ray crystallography; Acidic phospholipase A2; Bothrops jararacussu venom; Platelet aggregation and hypotensive effects; Crysta


Alimentação XML